Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S H Chiu

Showing results (31-40 of 65) with videos related to

Pageof 7
Sort By:
Drug Metabolism and Disposition: the Biological Fate of Chemicals|July 1, 1984
The metabolism of avermectin-H2B1a and -H2B1b by pig liver microsomesS H Chiu, E Sestokas, R Taub, et al.
Biochemical Pharmacology|May 1, 1991
Effects of the immunosuppressant FK-506 and its analog FK-520 on hepatic and renal cytochrome P450 mixed-function oxidaseS H Vincent, R W Wang, B V Karanam, et al.
Transplantation|August 25, 1999
Mycophenolic acid increases apoptosis, lysosomes and lipid droplets in human lymphoid and monocytic cell linesR G Cohn, A Mirkovich, B Dunlap, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|October 26, 1999
Substance P receptor antagonist I: conversion of phosphoramidate prodrug after i.v. administration to rats and dogsS E Huskey, D Luffer-Atlas, B J Dean, et al.
Hong Kong Medical Journal = Xianggang Yi Xue Za Zhi|February 4, 2010
Transcatheter embolisation of intrahepatic arteriovenous shunts in patients with hepatocellular carcinomaW S W Chan, W L Poon, D H Y Cho, et al.
Organic Letters|November 14, 2000
A rotaxane-like complex with controlled-release characteristicsS H Chiu, S J Rowan, S J Cantrill, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|September 1, 1988
Comparative metabolic disposition of ivermectin in fat tissues of cattle, sheep, and ratsS H Chiu, J R Carlin, R Taub, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|August 1, 1997
Orally active inhibitors of human leukocyte elastase. III. Identification and characterization of metabolites of L-694,458 by liquid chromatography-tandem mass spectrometryD Luffer-Atlas, S H Vincent, S K Painter, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|March 1, 1992
The metabolism of DuP 753, a nonpeptide angiotensin II receptor antagonist, by rat, monkey, and human liver slicesR A Stearns, R R Miller, G A Doss, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|July 1, 1993
Evidence for a 1,2-hydride shift in the microsomal metabolism of the heterocycle L-158,338, a nonpeptide angiotensin II receptor antagonistR A Stearns, R R Miller, B H Arison, et al.
Pageof 7

Showing results (31-40 of 65) with videos related to

Sort By:
Pageof 7
Drug Metabolism and Disposition: the Biological Fate of Chemicals|July 1, 1984
The metabolism of avermectin-H2B1a and -H2B1b by pig liver microsomesS H Chiu, E Sestokas, R Taub, et al.
Biochemical Pharmacology|May 1, 1991
Effects of the immunosuppressant FK-506 and its analog FK-520 on hepatic and renal cytochrome P450 mixed-function oxidaseS H Vincent, R W Wang, B V Karanam, et al.
Transplantation|August 25, 1999
Mycophenolic acid increases apoptosis, lysosomes and lipid droplets in human lymphoid and monocytic cell linesR G Cohn, A Mirkovich, B Dunlap, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|October 26, 1999
Substance P receptor antagonist I: conversion of phosphoramidate prodrug after i.v. administration to rats and dogsS E Huskey, D Luffer-Atlas, B J Dean, et al.
Hong Kong Medical Journal = Xianggang Yi Xue Za Zhi|February 4, 2010
Transcatheter embolisation of intrahepatic arteriovenous shunts in patients with hepatocellular carcinomaW S W Chan, W L Poon, D H Y Cho, et al.
Organic Letters|November 14, 2000
A rotaxane-like complex with controlled-release characteristicsS H Chiu, S J Rowan, S J Cantrill, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|September 1, 1988
Comparative metabolic disposition of ivermectin in fat tissues of cattle, sheep, and ratsS H Chiu, J R Carlin, R Taub, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|August 1, 1997
Orally active inhibitors of human leukocyte elastase. III. Identification and characterization of metabolites of L-694,458 by liquid chromatography-tandem mass spectrometryD Luffer-Atlas, S H Vincent, S K Painter, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|March 1, 1992
The metabolism of DuP 753, a nonpeptide angiotensin II receptor antagonist, by rat, monkey, and human liver slicesR A Stearns, R R Miller, G A Doss, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|July 1, 1993
Evidence for a 1,2-hydride shift in the microsomal metabolism of the heterocycle L-158,338, a nonpeptide angiotensin II receptor antagonistR A Stearns, R R Miller, B H Arison, et al.
Pageof 7